510(k) DEN220023

Procise ADL by Procisedx, Inc. — Product Code QYD

Clearance Details

Decision
DENG (De Novo Granted)
Decision Date
September 29, 2023
Date Received
April 4, 2022
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Adalimumab Assay
Device Class
Class II
Regulation Number
862.3115
Review Panel
TX
Submission Type

An in vitro diagnostic device intended for the measurement of adalimumab, an anti-tumor necrosis factor alpha monoclonal antibody